FDA-Approved Schizophrenia and Bipolar I Disorder Treatment Includes Compound Discovered at Rensselaer
The U.S. Food and Drug Administration has approved a new drug for treating schizophrenia and bipolar I disorder that includes samidorphan, a new chemical entity discovered at Rensselaer Polytechnic Institute.